Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Diabetes Complications. 2020 Nov 26;35(3):107805. doi: 10.1016/j.jdiacomp.2020.107805

Table 3:

Linear regression of cognition tests with albuminuria (≥ 30 mg/gram creatinine) and eGFR <60 ml/minute/1.73m2; β with 95% CI.

SEVLT DSST Word Fluency Letters Word Fluency Animal
Model 1
ALB ≥30 −0.06 (−0.62, 0.50) −0.66 (−1.58, 0.26) −0.14 (−0.47, 0.19) −0.17 (−0.56, 0.21)
eGFR <60 −1.04 (−2.35, 0.28) −1.72 (−3.89, 0.46) −0.46 (−1.24, 0.33) −0.64 (−1.55, 0.27)
Model 2
ALB ≥30 −0.19 (−0.73, 0.36 −0.70 (−1.58, 0.16) −0.12 (−0.45, 0.20) −0.31 (−0.68, 0.07)
eGFR <60 −1.09 (−2.37, 0.18) −1.60 (−3.62, 0.42) −0.40 (−1.16, 0.37) −0.60 (−1.48, 0.28)
Model 3
ALB ≥ 30* −0.17 (−0.72, 0.37) −0.67 (−1.54, 0.19) −0.12 (−0.45, 0.21) −0.30 (−0.68, 0.72)
eGFR <60 −1.03 (−2.31, 0.24) −1.59 (−3.61, 0.43) −0.38 (−1.15, 0.38) −0.55 (−1.43, 0.33)

Model 1: Adjusted for age, sex, race, Hispanic ethnicity, and an interaction term for age × sex.

Model 2: Model 1 plus education level, waist circumference, current smoking, alcohol status, history of stroke, HTN, hyperlipidemia and depression.

Model 3: Model 2 plus screening HbA1c, and either eGFR or UACR. In model 3 interaction terms were included for: sex (M vs F), age (<55 vs ≥55 years), lipid treatment and/or TC >240 (Y vs N), and by age × sex categories.

*

There were no significant interactions for < vs ≥ 30 mg/g creatinine.

There were no significant interactions for eGFR < vs ≥60 ml/minute/1.73m2.